NDC 46708-525 – doxorubicin hydrochloride
Doxorubicin Hydrochloride 2 mg/mL · Injection, Suspension, Liposomal · Intravenous
Product NDC46708-525
Product details
- Brand name
- doxorubicin hydrochloride
- Generic name
- doxorubicin hydrochloride
- Labeler
- Alembic Pharmaceuticals Limited
- Dosage form
- Injection, Suspension, Liposomal
- Route
- Intravenous
- Marketing category
- ANDA · ANDA219199
- Marketed since
- June 27, 2025
- Listing expires
- December 31, 2026
- Pharmacologic class
- Anthracycline Topoisomerase Inhibitor
Active ingredients
- Doxorubicin Hydrochloride 2 mg/mL
Uses, dosage, side effects and warnings for Doxorubicin Hydrochloride →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 46708-525-25 | 1 VIAL, SINGLE-DOSE in 1 CARTON (46708-525-25) / 25 mL in 1 VIAL, SINGLE-DOSE | Jun 27, 2025 |
Other Doxorubicin Hydrochloride products
- 45963-733 Doxorubicin Hydrochloride 2 mg/mL · Injection, Solution · Actavis Pharma, Inc.
- 62332-525 Doxorubicin Hydrochloride 2 mg/mL · Injection, Suspension, Liposomal · Alembic Pharmaceuticals Inc.
- 62332-810 Doxorubicin Hydrochloride 2 mg/mL · Injection, Suspension, Liposomal · Alembic Pharmaceuticals Inc.
- 46708-810 Doxorubicin Hydrochloride 2 mg/mL · Injection, Suspension, Liposomal · Alembic Pharmaceuticals Limited
- 70121-1219 Doxorubicin Hydrochloride 2 mg/mL · Injection, Powder, Lyophilized, For Solution · Amneal Pharmaceuticals LLC
- 70121-1218 Doxorubicin Hydrochloride 2 mg/mL · Injection, Powder, Lyophilized, For Solution · Amneal Pharmaceuticals LLC
- 68001-703 Doxorubicin Hydrochloride 2 mg/mL · Injectable, Liposomal · BluePoint Laboratories
- 68001-492 Doxorubicin Hydrochloride 2 mg/mL · Injectable, Liposomal · BluePoint Laboratories
- 68001-345 Doxorubicin Hydrochloride 2 mg/mL · Injectable, Liposomal · BluePoint Laboratories
- 68001-629 Doxorubicin Hydrochloride 2 mg/mL · Injection, Suspension, Liposomal · BluePoint Laboratories
- 68001-704 Doxorubicin Hydrochloride 2 mg/mL · Injectable, Liposomal · BluePoint Laboratories
- 68001-706 Doxorubicin Hydrochloride 2 mg/mL · Injection, Suspension, Liposomal · BluePoint Laboratories